These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32718288)

  • 1. Management of Glioblastoma Multiforme by Phytochemicals: Applications of Nanoparticle-Based Targeted Drug Delivery System.
    Mumtaz SM; Bhardwaj G; Goswami S; Tonk RK; Goyal RK; Abu-Izneid T; Pottoo FH
    Curr Drug Targets; 2021; 22(4):429-442. PubMed ID: 32718288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.
    Pistollato F; Bremer-Hoffmann S; Basso G; Cano SS; Elio I; Vergara MM; Giampieri F; Battino M
    Target Oncol; 2016 Feb; 11(1):1-16. PubMed ID: 26275397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
    Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
    AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Bioactive Compounds: Alternative Approach to the Treatment of Glioblastoma Multiforme.
    Desai V; Bhushan A
    Biomed Res Int; 2017; 2017():9363040. PubMed ID: 29359162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
    Gutkin A; Cohen ZR; Peer D
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin: A promising phytochemical for the treatment of glioblastoma multiforme.
    Tavana E; Mollazadeh H; Mohtashami E; Modaresi SMS; Hosseini A; Sabri H; Soltani A; Javid H; Afshari AR; Sahebkar A
    Biofactors; 2020 May; 46(3):356-366. PubMed ID: 31880372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy.
    Yasaswi PS; Shetty K; Yadav KS
    J Control Release; 2021 Aug; 336():549-571. PubMed ID: 34229001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities.
    Gupta T; Sahoo RK; Singh H; Katke S; Chaurasiya A; Gupta U
    AAPS PharmSciTech; 2023 Apr; 24(4):102. PubMed ID: 37041350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential of Curcumin in the Treatment of Glioblastoma Multiforme.
    Shahcheraghi SH; Zangui M; Lotfi M; Ghayour-Mobarhan M; Ghorbani A; Jaliani HZ; Sadeghnia HR; Sahebkar A
    Curr Pharm Des; 2019; 25(3):333-342. PubMed ID: 30864499
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Gallego L; Ceña V
    Expert Opin Drug Deliv; 2020 Nov; 17(11):1541-1554. PubMed ID: 32791861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival.
    Kim SS; Rait A; Kim E; Pirollo KF; Nishida M; Farkas N; Dagata JA; Chang EH
    ACS Nano; 2014 Jun; 8(6):5494-514. PubMed ID: 24811110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme.
    Jena L; McErlean E; McCarthy H
    Drug Deliv Transl Res; 2020 Apr; 10(2):304-318. PubMed ID: 31728942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide nanoparticles for targeted glioblastoma therapy.
    Fang C; Wang K; Stephen ZR; Mu Q; Kievit FM; Chiu DT; Press OW; Zhang M
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6674-82. PubMed ID: 25751368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Targeting by Liposome-Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells.
    Arcella A; Palchetti S; Digiacomo L; Pozzi D; Capriotti AL; Frati L; Oliva MA; Tsaouli G; Rota R; Screpanti I; Mahmoudi M; Caracciolo G
    ACS Chem Neurosci; 2018 Dec; 9(12):3166-3174. PubMed ID: 30015470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.